Inhaled tobramycin

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	23

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

trials per page:

Showing 1 to 10 of 23 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02677701 (ClinicalTrials.gov)	October 21, 2016	29/1/2016	Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycinin People With Cystic Fi ...	TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, ...	Cystic Fibrosis	Drug: azithromycin;Drug: placebo (for azithromycin);Drug: inhaled tobramycin	Seattle Children's Hospital	National Heart, Lung, and Blood Institute (NHLBI);Cystic Fibrosis Foundation;CF Therapeutics Develop ...	Completed	12 Years	N/A	All	119	Phase 4	United States
2	NCT02657473 (ClinicalTrials.gov)	August 13, 2016	13/1/2016	Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis	Long-term InhaledNebulized Tobramycinin Patients With Non-cystic Fibrosis Bronchiectasis. A Randomiz ...	Non-CF Bronchiectasis	Drug: tobramycin inhalation solution;Drug: Saline 0.9% inhalation solution	Medical Center Alkmaar	NULL	Completed	18 Years	N/A	All	58	Phase 2/Phase 3	Netherlands
3	EUCTR2016-000166-35-NL (EUCTR)	08/08/2016	17/05/2016	Inhaled nebulized tobramycin in non-CF bronchiectasis	Effects of long term ToBrAmycinInhalaTion SoluTion (TIS) once daiLy on Exacerbation rate in patients ...	Patients with non-cystic fibrosis bronchiectasis MedDRA version: 19.0;Level: PT;Classification code ...	Trade Name: Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution	Noordwest Ziekenhuisgroep	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2;Phase 3	Netherlands
4	NCT02449031 (ClinicalTrials.gov)	May 5, 2015	4/5/2015	Observational Study in Cystic Fibrosis Patients Using TOBI® Podhaler™ or Other FDA Approved InhaledA ...	A Prospective Observational Study in Cystic Fibrosis Patients With Chronic Respiratory Pseudomonas A ...	Pseudomonas Aeruginosa in Cystic Fibrosis	Drug: TOBI Podhaler;Drug: TOBI;Drug: Bethkis;Drug: Cayston	Mylan Inc.	Cystic Fibrosis Foundation	Active, not recruiting	6 Years	N/A	All	260		United States
5	NCT02113397 (ClinicalTrials.gov)	April 2014	9/4/2014	Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung	Comparative Evaluation of Bacterial Diversity and Richness in CF Lung in Patients Who Use Cycled Eve ...	Cystic Fibrosis	Drug: TOBI™ Podhaler™ 112 mg inhaled twice daily;Drug: Colistimethate 75 mg inhaled two times daily	Dartmouth-Hitchcock Medical Center	Novartis Pharmaceuticals	Terminated	12 Years	75 Years	All	1		United States
6	EUCTR2009-016590-15-PL (EUCTR)	03/12/2013	11/10/2013	A clinical trial to assess the treatment with nebulised tobramycinin terms of safety and ability to ...	A Randomized, Double-Blind, Placebo-Controlled, Crossover Multi-Center Study to Assess the Efficacya ...	Lung colonisation with Pseudomonas aeruginosa in cystic fibrosis patients MedDRA version: 14.1;Level ...	Trade Name: TOBI 300 mg / 5 mL nebuliser solution INN or Proposed INN: Tobramycin	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	50		United States;Greece;Russian Federation;Switzerland;Italy;France;Egypt;Hungary;Canada;Argentina;Pola ...
7	NCT01641822 (ClinicalTrials.gov)	December 2012	13/7/2012	Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regime ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalati ...	Cystic Fibrosis	Drug: AZLI;Drug: Placebo to match AZLI;Drug: Tobramycin inhalation solution	Gilead Sciences	NULL	Completed	6 Years	N/A	All	107	Phase 3	United States
8	EUCTR2009-016590-15-IT (EUCTR)	01/07/2011	14/03/2012	Evaluation of the efficacy and safety of tobramycinfor the treatment of early infections of P. aerug ...	A Randomized, Double-Blind, Placebo-Controlled, Crossover Multi-Center Study to Assess the Efficacy ...	Lung colonisation of Pseudomonas aeruginosa in cystic fibrosis patients. MedDRA version: 14.1;Level: ...	Trade Name: TOBI*NEBUL 56F 1D 300MG/5ML INN or Proposed INN: TOBRAMYCIN Other descriptive name: NA	NOVARTIS FARMA	NULL	Not Recruiting			Female: yes Male: yes	72		France;Hungary;Greece;Canada;Poland;Russian Federation;Germany;Switzerland;Italy
9	EUCTR2009-016590-15-DE (EUCTR)	19/07/2010	15/04/2010	A clinical trial to assess the treatment with nebulised tobramycinin terms of safety and ability to ...	A Randomized, Double-Blind, Placebo-Controlled, Crossover Multi-Center Study to Assess the Efficacya ...	Lung colonisation with Pseudomonas aeruginosa in cystic fibrosis patients MedDRA version: 14.1;Level ...	Trade Name: TOBI 300 mg/5 ml Lösung für einen Vernebler Product Name: TOBI Product Code: TBM100 INN or ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	50		France;Egypt;Hungary;Greece;Canada;Argentina;Poland;Romania;Russian Federation;Germany;Switzerland;I ...
10	EUCTR2009-016590-15-GR (EUCTR)	15/06/2010	31/12/2009	A Randomized, Double-Blind, Placebo-Controlled, Crossover Multi-Center Study to Assess the Efficacy ...	A Randomized, Double-Blind, Placebo-Controlled, Crossover Multi-Center Study to Assess the Efficacy ...	Lung colonisation of Pseudomonas aeruginosa in cystic fibrosis patients MedDRA version: 12.0;Level: ...	Trade Name: TOBI 300mg/5mL nebuliser solution Product Name: TOBI INN or Proposed INN: Tobramycin	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	72		France;Hungary;Greece;Poland;Germany;Italy

First Previous1 2 3Next Last